These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37863402)

  • 21. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.
    Martín-Martín L; López A; Vidriales B; Caballero MD; Rodrigues AS; Ferreira SI; Lima M; Almeida S; Valverde B; Martínez P; Ferrer A; Candeias J; Ruíz-Cabello F; Buadesa JM; Sempere A; Villamor N; Orfao A; Almeida J
    Oncotarget; 2015 Aug; 6(22):19204-16. PubMed ID: 26056082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
    Purkait S; Gupta S; Bakhshi S; Mallick S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
    Pagano L; Valentini CG; Grammatico S; Pulsoni A
    Br J Haematol; 2016 Jul; 174(2):188-202. PubMed ID: 27264021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
    Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
    Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
    Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X; Wu Y; Li C; Shen K; Li R
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological analysis of 46 cases with CD4
    Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
    Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic plasmacytoid dendritic cell neoplasm with a history of cytopenia: A case report.
    Yan M; Wang W; Cen X; Wang L; Sun Y; Wang B; Ou J; Nong L; Ren H; Zhu P; Wang M
    Diagn Cytopathol; 2020 Nov; 48(11):1102-1106. PubMed ID: 32374950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Ashok Kumar P; Ombada M; Pemmasani G; Tambe A; Banki K; Gentile T
    J Investig Med High Impact Case Rep; 2022; 10():23247096221127114. PubMed ID: 36341907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
    Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
    J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia?
    Wang W; Thakral B
    Blood; 2020 Sep; 136(13):1565. PubMed ID: 32970810
    [No Abstract]   [Full Text] [Related]  

  • 35. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
    Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
    Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
    Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
    Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
    Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
    Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
    Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.